Your browser doesn't support javascript.
loading
Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics.
Kamal, Mohamed A; Smith, Patrick F; Chaiyakunapruk, Nathorn; Wu, David B C; Pratoomsoot, Chayanin; Lee, Kenneth K C; Chong, Huey Yi; Nelson, Richard E; Nieforth, Keith; Dall, Georgina; Toovey, Stephen; Kong, David C M; Kamauu, Aaron; Kirkpatrick, Carl M; Rayner, Craig R.
Afiliação
  • Kamal MA; Regeneron Pharmaceuticals, Tarrytown, New York, USA.
  • Smith PF; Roche Innovation Center, New York, New York, USA.
  • Chaiyakunapruk N; d3 Medicine LLC - a Certara Company, Parsippany, New Jersey, USA.
  • Wu DBC; School of Pharmacy, Monash University Malaysia, Selangor, Malaysia.
  • Pratoomsoot C; School of Pharmacy, Monash University Malaysia, Selangor, Malaysia.
  • Lee KKC; Faculty of Public Health, Naresuan University, Thailand.
  • Chong HY; School of Pharmacy, Monash University Malaysia, Selangor, Malaysia.
  • Nelson RE; School of Pharmacy, Monash University Malaysia, Selangor, Malaysia.
  • Nieforth K; University of Utah, Salt Lake City, Utah, USA.
  • Dall G; d3 Medicine LLC - a Certara Company, Parsippany, New Jersey, USA.
  • Toovey S; d3 Medicine LLC - a Certara Company, Parsippany, New Jersey, USA.
  • Kong DCM; Pegasus, Basel, Switzerland.
  • Kamauu A; School of Pharmacy, Monash University Malaysia, Selangor, Malaysia.
  • Kirkpatrick CM; Anolinx LLC, Salt Lake City, Utah, USA.
  • Rayner CR; School of Pharmacy, Monash University Malaysia, Selangor, Malaysia.
Br J Clin Pharmacol ; 83(7): 1580-1594, 2017 07.
Article em En | MEDLINE | ID: mdl-28176362

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Análise Custo-Benefício / Influenza Humana / Oseltamivir / Pandemias Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Análise Custo-Benefício / Influenza Humana / Oseltamivir / Pandemias Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos